A recent FDA approval means consumers now have two GLP-1 weight loss pills to choose from as an alternative to the ...

The Food and Drug Administration has approved the second GLP-1 pill to treat obesity, this time from drugmaker Eli Lilly. The new pill, Foundayo, is taken once a day and will compete with the pill ...

Although GLP-1 pills and injections work similarly for weight loss management for people with obesity, they have different administration schedules and costs.

Eli Lilly said its closely watched obesity pill helped patients maintain the majority of their weight loss after they switched directly from taking Wegovy and Zepbound injections in a late-stage trial ...

We reviewed popular telehealth and pharmacy options for finding Zepbound online. Here are the top providers for safe access and ongoing support.